Correlation Between Verona Pharma and Verastem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Verastem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Verastem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Verastem, you can compare the effects of market volatilities on Verona Pharma and Verastem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Verastem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Verastem.

Diversification Opportunities for Verona Pharma and Verastem

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Verona and Verastem is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Verastem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verastem and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Verastem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verastem has no effect on the direction of Verona Pharma i.e., Verona Pharma and Verastem go up and down completely randomly.

Pair Corralation between Verona Pharma and Verastem

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.46 times more return on investment than Verastem. However, Verona Pharma PLC is 2.18 times less risky than Verastem. It trades about 0.27 of its potential returns per unit of risk. Verastem is currently generating about 0.04 per unit of risk. If you would invest  4,002  in Verona Pharma PLC on December 5, 2024 and sell it today you would earn a total of  2,748  from holding Verona Pharma PLC or generate 68.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  Verastem

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Verastem 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.

Verona Pharma and Verastem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and Verastem

The main advantage of trading using opposite Verona Pharma and Verastem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Verastem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verastem will offset losses from the drop in Verastem's long position.
The idea behind Verona Pharma PLC and Verastem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine